OptimizeRx hit a higher all-time peak (127% in FY2023-Q3).
| Metric | OptimizeRx | National Research |
|---|---|---|
| Latest NRR | 110% | 101% |
| All-time peak NRR | 127% | 105% |
| All-time low NRR | 110% | 101% |
| QoQ change | -6pp | +0pp |
| YoY change | -11pp | +0pp |
| 3-year change | - | - |
| Disclosures tracked | 12 | 8 |
| Metric | OptimizeRx | National Research |
|---|---|---|
| Total customers | - | - |
| Over $100K ARR | - | - |
| Over $1M ARR | - | - |
| Top-10 concentration | - | 17% |
| Average ACV | $3M | - |
| US revenue mix | - | - |
| Metric | OptimizeRx | National Research |
|---|---|---|
| Total RPO | - | $105M |
| Current RPO (12mo) | - | $82M |
| Multi-year contracts | - | - |
| Avg contract length | - | - |
| Subscription rev mix | 30% | 95% |
| New customers added | - | - |
| Metric | OptimizeRx | National Research |
|---|---|---|
| CS team size | - | - |
| Customers per CSM | - | - |
| Pricing model | hybrid | subscription |
| Renewal cadence | annual | multi-year |
| CSM coverage model | account-named | account-named |
| Top customer exec | Not Disclosed | Helen Hrdy |
Compute yours in 30 seconds. Get a live retention report showing where you stack up, your expansion gap, and which public companies sit closest to your numbers.